{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:25:12Z","timestamp":1775042712269,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.cpcardiol.2021.100999","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T14:33:26Z","timestamp":1632494006000},"page":"100999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Familial Hypercholesterolemia (FH) Registry Worldwide: A Systematic Review"],"prefix":"10.1016","volume":"47","author":[{"given":"Atefeh","family":"Amerizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaghayegh Haghjooy","family":"Javanmard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6828-2169","authenticated-orcid":false,"given":"Nizal","family":"Sarrafzadegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golnaz","family":"Vaseghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2021.100999_bib0001","article-title":"Saudi familial hypercholesterolemia patients with rare LDLR stop gain variant showed variable clinical phenotype and resistance to multiple drug regimen","volume":"8","author":"Awan","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0002","first-page":"32","article-title":"Familial hypercholesterolemia: review of diagnosis, screening, and treatment","volume":"62","author":"Turgeon","year":"2016","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijcard.2017.10.105","article-title":"Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: the heredity survey","volume":"252","author":"Faggiano","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038623","article-title":"Hokuriku-plus familial hypercholesterolaemia registry study: rationale and study design","volume":"10","author":"Tada","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0006","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tcm.2020.03.004","article-title":"Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels","volume":"31","author":"Bianconi","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.15420\/ecr.2018:10:2","article-title":"Familial hypercholesterolaemia diagnosis and management","volume":"13","author":"Alonso","year":"2018","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0009","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0010","first-page":"318","article-title":"The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark","volume":"49","author":"Jensen","year":"2002","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0011","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12929-016-0256-1","article-title":"The genetics and screening of familial hypercholesterolaemia","volume":"23","author":"Henderson","year":"2016","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0012","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0013","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0014","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ahj.2013.12.008","article-title":"Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry","volume":"167","author":"O'Brien","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF03401525","article-title":"An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)","volume":"16","author":"Rizos","year":"2017","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5001\/omj.2014.22","article-title":"Criteria for diagnosis of familial hypercholesterolemia: a comprehensive analysis of the different guidelines, appraising their suitability in the Omani Arab population","volume":"29","author":"Al-Rasadi","year":"2014","journal-title":"Oman Med J"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1570161116666181005125459","article-title":"The Gulf Familial Hypercholesterolemia Registry (Gulf FH): design, rationale and preliminary results","volume":"18","author":"Al-Rasadi","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0018","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1874192401711010066","article-title":"The spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: prime time for patient FH registry","volume":"11","author":"Alallaf","year":"2017","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0019","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jacl.2016.04.006","article-title":"Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: insights from SAFEHEART registry","volume":"10","author":"Alonso","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jacl.2014.11.008","article-title":"Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry","volume":"9","author":"Bamimore","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0021","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2018.08.010","article-title":"High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry","volume":"277","author":"B\u00e9liard","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0022","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2017.04.002","article-title":"Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry","volume":"262","author":"Bourbon","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0023","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.atherosclerosis.2018.05.040","article-title":"Familial hypercholesterolemia in Canada: initial results from the FH Canada National Registry","volume":"277","author":"Brunham","year":"2018","journal-title":"Atherosclerosis"},{"issue":"Suppl 1","key":"10.1016\/j.cpcardiol.2021.100999_bib0024","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.33549\/physiolres.933599","article-title":"ScreenPro FH: from the Czech MedPed to international collaboration. ScreenPro FH is a participating project of the EAS-FHCS","volume":"66","author":"Ceska","year":"2017","journal-title":"Physiol Res"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.36290\/vnl.2017.008","article-title":"ScreenPro FH - screening project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: rationale and design","volume":"63","author":"\u010ce\u0161ka","year":"2017","journal-title":"Vnitr Lek"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0026","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fphys.2019.00280","article-title":"Current status of familial hypercholesterolemia in China: a need for patient FH registry systems","volume":"10","author":"Chen","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0027","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.phrs.2017.12.015","article-title":"Evaluation of dyslipidaemia and the impact of hypolipidemic therapy on prognosis in high and very high risk patients through the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) Registry","volume":"132","author":"Dyrbu\u015b","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0028","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5543\/tkda.2017.25800","article-title":"The rationale and design of the national familial hypercholesterolemia registries in Turkey: A-HIT1 and A-HIT2 studies","volume":"45","author":"Kay\u0131k\u00e7\u0131o\u011flu","year":"2017","journal-title":"Turk Kardiyol Dern Ars"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0029","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.atherosclerosis.2018.06.695","article-title":"Incidence of familial hypercholesterolemia in patients from the Tercet registry","volume":"275","author":"Krzysztof","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.atherosclerosis.2018.06.011","article-title":"Latvian registry of familial hypercholesterolemia: the first report of three-year results","volume":"277","author":"Latkovskis","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0031","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacl.2020.12.001","article-title":"Familial hypercholesterolemia in Mexico: initial insights from the national registry","volume":"15","author":"Mehta","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0032","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.atherosclerosis.2018.06.007","article-title":"The development of the Mexican Familial Hypercholesterolemia (FH) National Registry","volume":"277","author":"Mehta","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0033","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/jpm11060464","article-title":"The prevalence of heterozygous familial hypercholesterolemia in selected regions of the Russian federation: the FH-ESSE-RF study","volume":"11","author":"Meshkov","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0034","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3389\/fgene.2020.00914","article-title":"Genetics, screening, and treatment of familial hypercholesterolemia: experience gained from the implementation of the Vietnam familial hypercholesterolemia registry","volume":"11","author":"Truong","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0035","first-page":"53","article-title":"CASCADE screening and registry of familial hypercholesterolemia in Iran: rationale and design","volume":"15","author":"Vaseghi","year":"2019","journal-title":"ARYA Atheroscler"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0036","doi-asserted-by":"crossref","first-page":"25","DOI":"10.36290\/vnl.2017.005","article-title":"ScreenPro FH - screening project for familial hypercholesterolemia in Central, Southern and Eastern Europe: basic epidemiology","volume":"63","author":"\u010ce\u0161ka","year":"2017","journal-title":"Vnitr Lek"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0037","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2019.06.899","article-title":"The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: results from the TERCET registry with 19,781 individuals","volume":"288","author":"Dyrbu\u015b","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251560","article-title":"Familial hypercholesterolemia in the Arabian Gulf Region: clinical results of the Gulf FH registry","volume":"16","author":"Alhabib","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0039","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/MJT.0000000000001087","article-title":"Factors associated with low-density lipoprotein cholesterol reduction in patients with familial hypercholesterolemia: results from Isfahan familial hypercholesterolemia registry","volume":"27","author":"Vaseghi","year":"2020","journal-title":"Am J Ther"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9913969","article-title":"Familial Hypercholesterolemia (FH) in Iran: findings from the four-year FH Registry","volume":"2021","author":"Vaseghi","year":"2021","journal-title":"J Lipids"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0041","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1157\/13117730","article-title":"[Cost-effectiveness of managing familial hypercholesterolemia using atorvastatin-based preventive therapy]","volume":"61","author":"Alonso","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0042","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.3390\/ijms19113426","article-title":"Familial hypercholesterolemia: the most frequent cholesterol metabolism disorder caused disease","volume":"19","author":"Benito-Vicente","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0043","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.mayocp.2016.04.013","article-title":"My approach to the patient with familial hypercholesterolemia","volume":"91","author":"Safarova","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0044","unstructured":"Goldstein J. The metabolic basis of inherited disease. Familial hypercholesterolemia. 1995:1981-2030."},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0045","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0046","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0047","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0048","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0049","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2009.09.014","article-title":"Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands","volume":"209","author":"Pijlman","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and treatment of heterozygous familial hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0051","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3389\/fphar.2018.00707","article-title":"Familial hypercholesterolemia: new horizons for diagnosis and effective management","volume":"9","author":"Mytilinaiou","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0052","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.2017.8543","article-title":"Cascade screening for familial hypercholesterolemia and the use of genetic testing","volume":"318","author":"Knowles","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0053","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2017.10.006","article-title":"Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH\u2122 patient registry","volume":"267","author":"Amrock","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0054","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11883-020-00881-5","article-title":"Women living with familial hypercholesterolemia: challenges and considerations surrounding their care","volume":"22","author":"Balla","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2018.01.034","article-title":"A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)","volume":"270","author":"Kayikcioglu","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.100999_bib0056","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.atherosclerosis.2018.08.017","article-title":"Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)","volume":"277","author":"Rizos","year":"2018","journal-title":"Atherosclerosis"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621002140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621002140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:00:31Z","timestamp":1758938431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280621002140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0146280621002140"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100999","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial Hypercholesterolemia (FH) Registry Worldwide: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100999"}}